Browse by Person
 | Up a level |
Guzman, Juan D. and Pesnot, T. and Barrera, D.A. and Davies, H.M. and McMahon, E. and Evangelopoulos, Dimitrios and Mortazavi, Parisa Nakhostin and Munshi, Tulika and Maitra, Arundhati and Lamming, E.D. and Angell, R. and Gershater, M.C. and Redmond, J.M. and Needham, D. and Ward, J.M. and Cuca, L.E. and Hailes, H.C. and Bhakta, Sanjib (2015) Tetrahydroisoquinolines affect the whole-cell phenotype of Mycobacterium tuberculosis by inhibiting the ATP-dependent MurE ligase. Journal of Antimicrobial Chemotherapy 70 (6), pp. 1691-1703. ISSN 0305-7453.
Lichman, B.R. and Gershater, M.C. and Lamming, E.D. and Pesnot, T. and Sula, Altin and Keep, Nicholas H. and Hailes, H.C. and Ward, J.M. (2015) 'Dopamine-first' mechanism enables the rational engineering of the norcoclaurine synthase aldehyde activity profile. FEBS Journal 282 (6), pp. 1137-1151. ISSN 1742-464X.
Sayer, J.R. and Walldén, Karin and Pesnot, T. and Campbell, F. and Gane, P.J. and Simone, M. and Koss, H. and Buelens, Floris and Boyle, T.P. and Selwood, D.L. and Waksman, Gabriel and Tabor, A.B. (2014) 2- and 3-substituted imidazo [1,2-a] pyrazines as inhibitors of bacterial type IV secretion. Bioorganic & Medicinal Chemistry 22 (22), pp. 6459-6470. ISSN 0968-0896.